UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Sphere Entertainment
SPHR
$5.83B
| $2.37M | ﹤0.01% |
28,403
+3,300
| +13% | +$248K |
|
3277
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.12B
| $2.37M | ﹤0.01% |
21,926
+1,020
| +5% | +$111K |
|
3278
CALL
Monster Beverage
MNST
$89.2B
| $2.37M | ﹤0.01% |
118,400
-50,800
| -30% | -$1.07M |
|
3279
Agree Realty
ADC
$9.13B
| $2.36M | ﹤0.01% |
35,605
+26,892
| +309% | +$1.75M |
|
3280
ePlus
PLUS
$2.32B
| $2.36M | ﹤0.01% |
42,102
-5,383
| -11% | -$268K |
|
3281
CBIZ
CBZ
$2.96B
| $2.36M | ﹤0.01% |
56,210
-20,260
| -26% | -$793K |
|
3282
Innovator S&P Investment Grade Preferred ETF
EPRF
$68.3M
| $2.36M | ﹤0.01% |
108,477
-53,245
| -33% | -$1.19M |
|
3283
MidCap Financial Investment
MFIC
$804M
| $2.35M | ﹤0.01% |
177,840
+10,289
| +6% | +$137K |
|
3284
Omnicell
OMCL
$1.68B
| $2.35M | ﹤0.01% |
18,153
-10,304
| -36% | -$1.49M |
|
3285
GitLab
GTLB
$7.11B
| $2.34M | ﹤0.01% |
42,888
+24,820
| +137% | +$1.48M |
|
3286
BlackRock Floating Rate Income Strategies Fund
FRA
$391M
| $2.33M | ﹤0.01% |
179,306
+1,416
| +0.8% | +$19K |
|
3287
Denison Mines
DNN
$3B
| $2.33M | ﹤0.01% |
1,459,121
+82,518
| +6% | +$116K |
|
|
LICY
3288
DELISTED
Li-Cycle Holdings Corp.
LICY
| $2.33M | ﹤0.01% |
34,525
-34,516
| -50% | -$2.2M |
|
3289
CALL
DaVita
DVA
$11.4B
| $2.33M | ﹤0.01% |
+20,600
| New | +$2.31M |
|
3290
BioCryst Pharmaceuticals
BCRX
$2.64B
| $2.33M | ﹤0.01% |
143,148
-389,502
| -73% | -$6.25M |
|
|
ICPT
3291
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.33M | ﹤0.01% |
143,080
| – | – |
|
3292
Primerica
PRI
$9.63B
| $2.33M | ﹤0.01% |
17,006
-20,959
| -55% | -$2.98M |
|
3293
Camping World
CWH
$655M
| $2.33M | ﹤0.01% |
83,164
-228,056
| -73% | -$7.47M |
|
3294
3D Systems Corp
DDD
$633M
| $2.32M | ﹤0.01% |
139,356
-6,513
| -4% | -$113K |
|
3295
Gildan
GIL
$10.8B
| $2.32M | ﹤0.01% |
62,001
+9,753
| +19% | +$383K |
|
3296
Installed Building Products
IBP
$6.63B
| $2.32M | ﹤0.01% |
27,507
-6,959
| -20% | -$736K |
|
3297
Pebblebrook Hotel Trust
PEB
$2.01B
| $2.32M | ﹤0.01% |
94,725
-66,422
| -41% | -$1.53M |
|
|
ROCC
3298
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.32M | ﹤0.01% |
67,074
-40,140
| -37% | -$1.31M |
|
3299
Atara Biotherapeutics
ATRA
$80.6M
| $2.32M | ﹤0.01% |
9,971
+147
| +1% | +$46.8K |
|
3300
CALL
KB Home
KBH
$3.54B
| $2.31M | ﹤0.01% |
71,500
-109,400
| -60% | -$4.31M |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,161 positions and reducing 5,174 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,181 new positions and closed 1,161 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.